CA
CA · CA · CA-DIN-02511355
KESIMPTA
ATC L04AG12
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerNOVARTIS PHARMACEUTICALS CANADA INC
CountryCA (CA)
ATC codeL04AG12
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02511355",
"form": "SOLUTION",
"class": "Human",
"routes": [
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L04AG12",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "100057",
"strengths": [
"20 MG"
],
"ahfs_class": null,
"substances": [
"OFATUMUMAB"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code L04AG12.
- GBArzerra 1000mg/50ml concentrate for solution for infusion vialsNovartis Pharmaceuticals UK Ltd
- GBArzerra 100mg/5ml concentrate for solution for infusion vialsNovartis Pharmaceuticals UK Ltd
- PLKesimptaNovartis Ireland Ltd
- ISKesimptaNovartis Europharm Limited*
- 🇨🇭KesimptaNovartis Pharma Schweiz AG
- FIKesimptaNovartis Europharm Limited
- DKKesimptaNovartis Europharm Limited
- ISKesimptaNovartis Europharm Limited*
Access this data programmatically
Query KESIMPTA and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.